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Abstract
Introduction. Obstructive sleep apnea syndrome (OSAS) is strongly associated with adverse cardiovascular outcomes, 
however the relation between OSAS severity and troponin T (TnT) remain unclear.
Material and methods. Diagnosis and assessment of OSAS severity was based on non-supervised, overnight screening 
polysomnography (PSG) performed without an adaptation night. The study group consisted of 72 patients diagnosed 
with OSAS (including 31 with mild, 10 with moderate and 31 patients with severe OSAS), whereas the control group con-
tained 16 individuals. PSG was performed with equipment fulfilling the criteria of type III diagnostic devices according 
to the American Academy of Sleep Medicine.
Results. Revealed significant differences in troponin T levels between patients with severe OSAS and controls (p = 0.02) 
as well as in patients with severe and with mild OSAS (p = 0.04). The factors substantially affecting TnT concentrations 
were found to be apnea–hypopnea index (AHI), apnea index (AI), hypopnea index (HI) and minimum nocturnal saturation.
Conclusions. The relationship between sleep apnea syndrome and the level of serum TnT confirms that OSAS pre-
disposes to myocardial damage in a manner dependent on the severity of sleep apnea. The increase in troponin level 
is mainly associated with AHI and minimum nocturnal saturation. This suggests that early treatment of OSAS patients 
may protect against myocardial injury.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is a condition 
caused by episodes of breathing disorders in the form 
of short-term pauses in breathing during sleep. Apnea is 
defined as cessation of respiration for 10 seconds or more 
that results in a reduction of airflow to 90% below normal 
caused by limited airflow at the level of the pharynx asso-
ciated with enhanced work of respiratory muscles. A sum 
of all apneas and hypopneas per one hour of sleep, i.e. 
the apnea–hypopnea index (AHI), is a key criterion for the 
diagnosis and classification of OSAS [1]. According to AHI 
values, OSAS is divided into mild, moderate and severe. 
Obstructive sleep apnea affects about 9–26% of the adult 
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population and even 70% of individuals > 60 years of age 
[2, 3]. OSAS is considered one of the risk factors of such 
diseases as arterial hypertension, metabolic syndrome, 
heart failure or coronary disease [4].
Cardiac troponins are specific markers mainly used to 
diagnose acute coronary syndromes. Their increases are 
observed in myocardial damage associated with ische-
mia, trauma or inflammation. Moreover, cardiac troponins 
increase during pulmonary and renal diseases, cerebral 
stroke or chronic circulatory failure. Even slight elevations 
in troponins are likely to be associated with subclinical 
myocardial damage [5]. The damage is directly proportio-
nal to their increase. Regardless the underlying reason of 
troponin T (TnT) elevation, its increase is considered strong 
and independent predictor of cardiac injury and worse 
prognosis [6]. Only a few studies have assessed relation 
between the troponin level and severity of sleep apnea and 
their findings are often inconsistent [7].
The aim of the study was to assess the parameters 
affecting TnT levels in patients with OSAS.
Material and methods
An observational, cross-sectional study was undertaken. 
Its design was approved by the Bioethics Committee of the 
Medical University of Lublin; all the patients enrolled in the 
study gave their written informed consent for participation.
Patients
The study encompassed individuals referred to the sleep 
laboratory of the University Hospital in Lublin due to sus-
pected breathing disorders during sleep.
The exclusion criteria were history of ischemic heart 
disease, prior myocardial infarction, chronic heart failure, 
chronic obstructive lung disease, chronic kidney diseases 
— stages III–V, acute and chronic liver damage, acute in-
fections and PSG-detected breathing disorders other than 
OSAS. The control group included individuals subjected to 
PSG, which excluded sleep breathing disorders.
Polysomnography
Diagnosis and assessment of OSAS severity was based on 
non-supervised, overnight screening PSG performed with 
an adaptation night. SleepDoc Porti 6 and Porti 8 systems 
(Dr. Fenyves und Gut Deutschland GmbH) were used ful-
filling the criteria of type III diagnostic devices according 
to the American Academy of Sleep Medicine (AASM). The 
following parameters were recorded and analyzed: the 
apnea–hypopnea index (AHI) defined as the number of 
apneas and hypopneas per one hour of examination, 
apnea index (AI) and hypopnea index (HI) reflecting the 
number of apneas and hypopneas per one hour of exami-
nation, respectively, respiratory distress time (RDT), i.e. 
total duration of apneas and hypopneas during the entire 
examination in minutes, respiratory distress time index 
(RDTI), i.e. duration of apneas and hypopneas over one 
hour of examination, mean and minimum saturation (SpO2) 
during the examination, and time of hypoxia/hypoxemia 
(t90), defined as the percentage of examination time with 
saturation below 90%.
According to the AASM recommendations, the following 
criteria for OSAS diagnosis were accepted: AHI ≥ 15/h or 
AHI ≥ 5/h accompanied by typical clinical symptoms.
Three degrees of OSAS severity were distinguished: 
mild with AHI ≥ 5/h and < 15/h, with accompanying clini-
cal symptoms, moderate with AHI ≥ 15/h and < 30/h and 
severe with AHI ≥ 30/h.
Biochemical measurements
The material for the study was the peripheral blood obtai-
ned from the ulnar vein. Blood samples were collected after 
an 8–12 hours overnight fast between 8:00 and 10:00 am 
into clot tubes in volumes of 7 ml. Troponin T concentrations 
were determined using an automated immunochemilumi-
nescence analyzer.
Statistical analysis
STATISTICA 10 PL software (Statsoft Inc., USA) was used 
for statistical analysis of data. P < 0.05 was considered 
statistically significant. For descriptive statistics, the mean 
and standard deviation (SD) were used as a measure of 
dispersion. Normality of distribution was checked with 
the Shapiro-Wilk W test. The Student’s t-test was applied 
to check the significance of differences for two indepen-
dent samples (normal distribution) when homogeneity 
of variance was confirmed (the Levene’s test). In cases 
of non-homogenous variance or variables of non-normal 
distribution, the Mann-Whitney U test was used. Inter-
group differences in qualitative variables were analyzed 
using the χ2 test. To compare the differences in depen-
dent variables in more than two groups, univariate and 
multivariate ANOVA tests were applied. The Tukey’s test 
was employed for detailed identification of statistically 
different groups. The strength and direction of correlations 
between two variables was examined using the Pearson 
linear correlation coefficient (for normal distribution of 
variables) or the Spearman rank correlation test (when 
the distribution was not normal).
Results
The control group consisted of 16 subjects without bre-
athing disorders during sleep whereas the study group 
encompassed 72 patients with confirmed OSAS (including 
31 with mild, 10 with moderate and 31 patients with seve-
re OSAS). Demographic characteristics and basic clinical 
data of the control and study groups were listed in Table 1; 
biochemical findings were presented in Table 2.
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One-way ANOVA demonstrated significant differences 
in TnT levels (p = 0.02). The Tukey’s test for multiple 
comparisons revealed significant differences in TnT levels 
between patients with severe OSAS and controls (p = 0.02) 
as well as between patients with severe OSAS and mild 
OSAS (p =  0.04) (Fig. 1).
Considering inter-subgroup differences in gender struc-
ture, bivariate ANOVA was applied; the results did not show 
any significant influence of gender on TnT concentration.
Statistically significant correlations were found between 
TnT concentration and AHI, AI, HI, RDT, RDTI, and minimum 
SpO2 (Table 3).
Discussion
OSAS adversely affects the functioning of the myocardium 
and leads to its remodeling. Higher degrees of OSAS 
severity have been demonstrated to be associated with 
increased morbidity and mortality due to cardiovascular 
Table 1. Demographical and clinical characteristics of patients
Parameter Control group 
(n = 16)
Mild OSAS 
(n = 31)
Moderate 
OSAS (n = 10)
Severe OSAS 
(n = 30)
Age (yrs) 50.2 ± 14.8 52.7 ± 12.3 56.8 ± 8.8 54.3 ± 12
No. of males [%] 56 60 93 82
AHI [h-1] 2.1 ± 1.7 10.5 ± 5.6 21.7 ± 5.4 53.6 ± 16.8
AI [h-1] 0.5 ± 0.6 4.4 ± 2.9 12.8 ± 6.4 41.5 ± 19.9
HI [h-1] 1.6 ± 1.5 6 ± 4.6 8.9 ± 4.4 11.9 ± 9.5
RDT [min] 4.6 ± 5.3 21.6 ± 9.1 51 ± 22.2 141.3 ± 64.2
RDTI [min/h] 1.7 ± 4.9 3.4 ± 1.9 8.6 ± 4.5 24 ± 9.9
Minimal SpO2 [%] 85.9 ± 4.5 81.2 ± 4.8 77 ± 7.2 66.7 ± 12.7
Mean SpO2 [%] 92.7 ± 1.6 91.6 ± 1.8 91.3 ± 2.1 88.7 ± 3.9
Time of hypoxemia [%] 1.6 ± 3.3 6.3 ± 13.8 11.5 ± 17.1 32.2 ± 24.4
Arterial hypertension [%] 78 64 79 79
Type 2 diabetes [%] 11 33 54 21
OSAS — obstructive sleep apnea syndrome; AHI — apnea–hypopnea index; AI — apnea index; HI — hypopnea index; RDT — respiratory distress time; RDTI — respiratory distress time index; SpO2 — saturation
Table 2. Biochemical characteristics of patients
Parameter Control group 
(n = 16)
Mild OSAS 
(n = 31)
Moderate OSAS 
(n = 10)
Severe OSAS 
(n = 30)
Hemoglobin [g/dL] 14.3 ± 1.65 14.5 ± 1.18 14.6 ± 1.37 14.7 ± 1.26
Creatinine [mg/dL] 0.81 ± 0.16 0.82 ± 0.17 0.86 ± 0.17 0.87 ± 0.18
Uric acid [mg/dL] 6.13 ± 1.24 6.47 ± 1.24 6.23 ± 0.83 6.46 ± 1.49
C-reactive protein [mg/L] 4.87 ± 9.07 2.85 ± 3.67 2.47 ± 2.37 4.7 ± 7.5
Potassium [mmol/L] 4.33 ± 0.36 4.23 ± 0.28 4.36 ± 0.34 4.32 ± 0.36
Thyreotropin [μIU/mL] 1.54 ± 0.78 1.91 ± 3.34 1.8 ± 1.77 2.07 ± 4.44
Troponin T [ng/mL] 0.005 ± 0.004 0.006 ± 0.004 0.0057 ± 0.004 0.01 ± 0.001
OSAS — obstructive sleep apnea syndrome
Figure 1. Troponin T concentration in patients with different gra-
des of obstructive sleep apnea syndrome (OSAS) and in controls; 
SE — standard error
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diseases [8]. In OSAS, cardiomyocyte damage can be rela-
ted to inadequate amounts of oxygen as well as activation 
of the sympathetic system and results in the development 
of tachycardia and oxidative stress. The cardiomyocytes 
exposed to such conditions are damaged releasing tro-
ponins [9]. The literature data regarding the relationship 
between TnT and OSAS are inconsistent. Gami et al. have 
demonstrated that the severity of OSAS is associated 
with higher levels of TnT, hence subclinical myocardial 
damage, which leads to myocardial failure [10]. According 
to Randy [11], the severity of OSAS, measured with AHI, 
is correlated with increased TnT. However, multivariate 
analysis has not revealed the aforementioned correlation. 
In our study, multivariate analysis showed the influence 
of AHI and minimum nocturnal saturation on TnT levels. 
Likewise, the total time of apneas and hypopneas during 
the entire examination (RDT) was statistically significantly 
correlated with increased TnT levels. The above findings 
allow supposing that OSAS is one of the factors that can 
damage the myocardium. Interestingly, some study fin-
dings suggest that chronic hypoxia of cardiomyocytes is 
likely to lead to their degeneration and apoptosis; on the 
other hand, ischemic preconditioning of the myocardium 
is observed, which can reduce the extent and severity of 
infarction, thus have protective effects [12, 13]. The above 
phenomenon and its clinical implications have not been 
fully elucidated; therefore, further studies are required. 
Repeated episodes of nocturnal hypoxemia result in endo-
thelial dysfunction and remodeling of vascular walls, thus 
can lead to the development of systemic and pulmonary 
hypertension [14]. Moreover, the degree of OSAS severity, 
defined by AHI, has been found to correlate with the con-
dition of coronary endothelial vessels and to affect their 
decongestion [15]. Our study revealed that the degree of 
OSAS correlated with an increase in TnT. Higher levels of 
TnT were observed in the group with severe OSAS; in mild 
and moderate OSAS groups, the levels of TnT were lower. 
The above suggests that individuals with the most severe 
form of OSAS are at the highest risk of myocardial dama-
ge yet can also benefit most from appropriate treatment. 
Our findings are comparable with those of other authors 
dealing with the issue in question [9, 10, 16]. Therefore, 
the earliest possible identification of patients with OSAS 
risk factors is essential as it enables early diagnosis and 
prompt initiation of CPAP therapy [17]. The information on 
a correlation between OSAS and elevated levels of tropo-
nins can be clinically important for differential diagnosis. 
Based on them, effective prophylaxis can be provided 
and the influence of OSAS on the heart monitored [18]. 
Furthermore, such data can help to decide about invasive 
or conservative management in patients with non-specific 
thoracic pain complaints.
Conclusions
The relationship between sleep apnea syndrome and the 
level of serum TnT confirms that OSAS predisposes to my-
ocardial damage in a manner dependent on the severity 
of sleep apnea. The increase in troponin level is mainly 
associated with AHI and minimum nocturnal saturation. 
This suggests that early treatment of OSAS patients may 
protect against myocardial injury.
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Table 3. Correlation between troponin T concentration and polysomnographic indices
Parameter Correlation coefficient p
Troponin T
AHI 0.25 0.02
AI 0.21 0.04
HI 0.25 0.02
RDT 0.25 0.02
RDTI 0.26 0.01
Mean SpO2 –0.11 NS
Minimum SpO2 –0.26 0.01
t90 0.19 NS
AHI — apnea–hypopnea index; AI — apnea index; HI — hypopnea index; RDT — respiratory distress time; RDTI — respiratory distress time index; SpO2 — saturation; NS — not significant
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Streszczenie
Wstęp. Zespół obturacyjnego bezdechu sennego (OSAS) jest silnie związany z występowaniem powikłań sercowo-
-naczyniowych. W dalszym ciągu zależność między nasileniem tego schorzenia a stężeniem troponiny T (TnT) pozostaje 
niejasna.
Materiał i metody. Rozpoznanie i ocenę stopnia ciężkości OSAS oparto na nienadzorowanej, całonocnej, przesiewowej 
polisomnografii (PSG), wykonywanej bez nocy adaptacyjnej. Grupa badana liczyła 72 pacjentów z potwierdzonym OSAS 
(w tym 31 chorych z łagodnym, 10 chorych z umiarkowanym oraz 31 pacjentów z ciężkim OSAS); grupa kontrolna liczyła 
16 osób bez zaburzeń oddychania w czasie snu. Do PSG użyto aparatów spełniających kryteria urządzeń diagnostycz-
nych klasy III według American Academy of Sleep Medicine.
Wyniki. Stwierdzono istotne statystycznie różnice pod względem stężeń TnT między chorymi z ciężkim OSAS w porów-
naniu z grupą kontrolną (p = 0,02) oraz osobami z łagodną postacią OSAS (p = 0,04). Wykazano, że czynnikami istotnie 
wpływającymi na stężenie TnT były wskaźnik oddech–spłycenie oddechu (AHI), wskaźnik oddechów (AI), wskaźnik spły-
ceń oddechu oraz minimalna nocna saturacja.
Wnioski. Zależność między OSAS i stężeniem TnT w surowicy potwierdza, że OSAS predysponuje do uszkodzenia mięśnia 
sercowego w sposób zależny od jego nasilenia. Wzrost stężenia TnT wiąże się przede wszystkim z AHI i minimalną nocną 
saturacją. Przedstawione wyniki wskazują, że wczesne leczenie pacjentów z OSAS może ich chronić przed uszkodzeniem 
mięśnia sercowego związanym z chorobą.
Słowa kluczowe: troponina T, obturacyjny bezdech senny, apnea–hypopnea index, uszkodzenie mięśnia sercowego, 
polisomnografia
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